WesBanco Bank’s Molecular Templates, Inc. MTEM Stock Holding History

WesBanco Bank’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-105	Closed	-$69K	–	551
2014 Q2	$69K	Hold	105	–	–	﹤0.01%	519
2014 Q1	$83K	Buy	+105	New	+$85.3K	﹤0.01%	515

Other funds holding MTEM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WesBanco Bank's MTEM Position: Q3 2014 in Review

WesBanco Bank sold out of Molecular Templates, Inc. (MTEM) in Q3 2014, closing a stake of 105 shares — an estimated $69K sold.

WesBanco Bank first reported a position in MTEM in Q1 2014 and held it in 2 quarters. The position peaked at $83K in Q1 2014. 92 funds tracked by Wall St. Rank hold MTEM as of Q3 2014.

WesBanco Bank reported no remaining Molecular Templates, Inc. position as of Q3 2014 after selling out during the quarter.
WesBanco Bank sold 105 Molecular Templates, Inc. shares in Q3 2014, an estimated $69K.
WesBanco Bank first reported a position in Molecular Templates, Inc. in Q1 2014 and held it in 2 quarters.
WesBanco Bank's Molecular Templates, Inc. position peaked at $83K in Q1 2014.
92 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2014.

Based on WesBanco Bank's 13F filing for Q3 2014, filed 6 Nov 2014.